“The Impact of CYP2C9 and VKORC1 Polymorphism in Patient’s Response to Warfarin and Acenocoumarol”, jmbas, vol. 7, no. 7, pp. 260–266, Jul. 2019, doi: 10.15520/jmbas.v7i7.193.